zirconium has been researched along with Angiogenesis, Pathologic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hatano, K; Iizumi, Y; Ishikawa, E; Joraku, A; Masuda, Y; Matsuda, M; Matsumura, A; Nishiyama, H; Yamamoto, T | 1 |
Arjaans, M; de Vries, EG; Garbacik, ET; Gietema, JA; Lub-de Hooge, MN; Oosting, SF; Oude Munnink, TH; Schröder, CP; Terwisscha van Scheltinga, AG; Timmer-Bosscha, H | 1 |
de Jong, JR; de Korte, MA; de Vries, EG; den Dunnen, WF; Garcia-Echeverria, C; Hollema, H; Jensen, MR; Lub-de Hooge, MN; Nagengast, WB; Oude Munnink, TH; Quadt, C; Schröder, CP; Timmer-Bosscha, H; van Dongen, GA | 1 |
Holland, JP; Lewis, JS; May, C; McDevitt, MR; Ruggiero, A; Scheinberg, DA; Sprinkle, SR; Villa, CH | 1 |
4 other study(ies) available for zirconium and Angiogenesis, Pathologic
Article | Year |
---|---|
Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with
Topics: Adult; Aged; Antigens, Surface; Brain; Brain Neoplasms; Endothelium, Vascular; Female; Glioma; Glutamate Carboxypeptidase II; Humans; Immunoglobulins; Lung Neoplasms; Lymphoma; Male; Middle Aged; Necrosis; Neovascularization, Pathologic; Positron-Emission Tomography; Radiation Injuries; Radioisotopes; Radiopharmaceuticals; Zirconium | 2018 |
Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cell Line, Tumor; Drug Interactions; Esophageal Neoplasms; Female; Humans; Immunoglobulin G; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Trastuzumab; Xenograft Model Antitumor Assays; Zirconium | 2013 |
89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cisplatin; Drug Resistance, Neoplasm; Female; HSP90 Heat-Shock Proteins; Immunohistochemistry; Isoxazoles; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Resorcinols; Tissue Distribution; Vascular Endothelial Growth Factor A; Zirconium | 2010 |
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
Topics: Actinium; Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Deferoxamine; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Nanomedicine; Nanotubes, Carbon; Neovascularization, Pathologic; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Xenograft Model Antitumor Assays; Zirconium | 2010 |